These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6176313)

  • 1. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group.
    Cancer; 1982 May; 49(9):1771-7. PubMed ID: 6176313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.
    Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK
    J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group.
    Cancer; 1990 Dec; 66(11):2324-30. PubMed ID: 1700927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report.
    Higgins GA; Amadeo JH; Smith DE; Humphrey EW; Keehn RJ
    Cancer; 1983 Sep; 52(6):1105-12. PubMed ID: 6349780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma.
    Gez E; Sulkes A; Yablonsky-Peretz T; Weshler Z
    J Surg Oncol; 1986 Feb; 31(2):139-42. PubMed ID: 3713191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of the disease-free interval in surgically treated rectal carcinoma.
    Gastrointestinal Tumor Study Group
    N Engl J Med; 1985 Jun; 312(23):1465-72. PubMed ID: 2859523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group.
    Cancer; 1982 Mar; 49(6):1116-22. PubMed ID: 7037156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer: current status of treatment.
    Carter SK; Comis RL
    J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).
    Engstrom PF; Lavin PT; Douglass HO; Brunner KW
    Cancer; 1985 May; 55(9):1868-73. PubMed ID: 3884131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
    Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
    N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
    Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
    J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
    J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group.
    Br J Surg; 1988 Nov; 75(11):1100-4. PubMed ID: 2905188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
    Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.
    O'Connell MJ; Martenson JA; Wieand HS; Krook JE; Macdonald JS; Haller DG; Mayer RJ; Gunderson LL; Rich TA
    N Engl J Med; 1994 Aug; 331(8):502-7. PubMed ID: 8041415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.
    Thomas PR; Lindblad AS; Stablein DM; Knowlton AH; Bruckner HW; Childs DS; Mittelman A
    Cancer; 1986 Mar; 57(6):1130-4. PubMed ID: 3943037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.